logo

For the Inventor, By the Inventor

Brussels, Belgium

Ucbbiopharma Srl


USPTO Granted Patents = 112



Trademarks = 64

Forward Citations = 81

Loading Chart...
Loading Chart...

221 inventors (with patents filed for the assignee):

goldMedal Kerry Louise Tyson (13 out of 38 patents)

silverMedal Daniel John Lightwood (12 out of 18 patents)

bronzeMedal Stephen Edward Rapecki (12 out of 28 patents)

4.  Terence Seward Baker (11 out of 34 patents)

5.  Sam Philip Heywood (10 out of 25 patents)

6.  James Philip O'Connell (10 out of 10 patents)

7.  John Robert Porter (10 out of 67 patents)

8.  David Paul Humphreys (9 out of 45 patents)

9.  Michael John Wright (9 out of 18 patents)

10.  Ralph Adams (9 out of 39 patents)

11.  Alastair Lawson (9 out of 12 patents)

12.  Jag Paul Heer (9 out of 17 patents)

13.  Timothy John Norman (9 out of 22 patents)

14.  David James McMillan (8 out of 10 patents)

15.  Helene Margaret Finney (7 out of 24 patents)


Core Competencies:
Multispecific Antibody Constructs
Tetrahydrobenzo-Quinoline Sulfonamides
Anti-Alpha-Synuclein Antibodies
Imidazopyridine Derivatives
Anti-FcRn Antibodies
Humanised Antibodies
Gremlin-1 Inhibitors
Medical Image Analysis
Cell Culture Methods
Anti-IgE Antibodies
Pharmaceutical Compositions
Protein Purification

112 patents:

1. 12516106 - METHOD FOR PROTEIN PURIFICATION (2026-01-06),
2. 12474348 - COMPLEXES BETWEEN CD40 AND COMPOUNDS COMPRISING BENZIMIDAZOLE MOIETIES (2025-11-18),
3. 12473355 - GREMLIN-1 CRYSTAL STRUCTURE AND INHIBITORY ANTIBODY (2025-11-18),
4. 12428497 - Multispecific antibody constructs (2025-09-30),
5. 12410244 - Anti-alpha-synuclein antibodies (2025-09-09),
6. 12410161 - Tetrahydrobenzo-quinoline sulfonamides derivative compounds (2025-09-09),
7. 12391688 - Imidazopyridine derivatives as IL-17 modulators (2025-08-19),
8. 12358890 - Substituted tetrahydroisoquinoline derivative as a D1 positive allosteric modulator (2025-07-15),
9. 12338285 - Anti-FcRn antibodies (2025-06-24),
10. 12331117 - Antibody molecules which bind CD22 (2025-06-17),
11. 12327614 - Multi-domain proteins with increased native state colloidal stability (2025-06-10),
12. 12327613 - De novo antibody design (2025-06-10),
13. 12296285 - Methods for purifying antibodies (2025-05-13),
14. 12275777 - Process for obtaining antibodies (2025-04-14),
15. 12240896 - Gremlin-1 inhibitor for the treatment of a bone fracture or bone defect (2025-03-04),
UCBBiopharma Srl is a pharmaceutical company dedicated to the research, development, and commercialization of innovative biopharmaceutical products. With a focus on improving patient care and addressing unmet medical needs, UCBBiopharma aims to make a significant impact on global healthcare. Headquartered in San Francisco, USA, the company collaborates with leading academic institutions and industry partners to advance biomedical research and deliver cutting-edge therapies to patients worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

112 Patents

#13 in Brussels

#46 in Belgium

#6,872 in the World

...
Brussels, Belgium

Ucbbiopharma Srl

Forward Citations = 81

221 inventors:

goldMedal Kerry Louise Tyson (13 out of 38 patents)

silverMedal Daniel John Lightwood (12 out of 18 patents)

bronzeMedal Stephen Edward Rapecki (12 out of 28 patents)

4.  Terence Seward Baker (11 out of 34 patents)

5.  Sam Philip Heywood (10 out of 25 patents)

Please report any incorrect information to support@idiyas.com
Loading…